CHUV
Les activités du CHUV
MENU
Centre de la prostate
Accueil > Recherche > Publications > Publications 2016

Publications de l'année 2016


Novelties in Urology in 2015

Jichlinski P.

Rev Med Suisse. 2016 Jan 13;12(500):95-6. French.

PMID:2694671

Addressing overtreatment following the diagnosis of localized prostate cancer.

Tawadros T, Valerio M.

Expert Rev Anticancer Ther. 2016;16(4):373-4. doi: 10.1586/14737140.2016.1143779. No abstract available.

PMID:26776104

The challenging landscape of medical device approval in localized prostate cancer.

Valerio M, Emberton M, Eggener SE, Ahmed HU.

Nat Rev Urol. 2016 Feb;13(2):91-8. doi: 10.1038/nrurol.2015.289. Review.

PMID:26666364

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.

James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Spears MR, Ritchie AW, Parker CC, Russell JM, Attard G, de Bono J, Cross W, Jones RJ, Thalmann G, Amos C, Matheson D, Millman R, Alzouebi M, Beesley S, Birtle AJ, Brock S, Cathomas R, Chakraborti P, Chowdhury S, Cook A, Elliott T, Gale J, Gibbs S, Graham JD, Hetherington J, Hughes R, Laing R, McKinna F, McLaren DB, O'Sullivan JM, Parikh O, Peedell C, Protheroe A, Robinson AJ, Srihari N, Srinivasan R, Staffurth J, Sundar S, Tolan S, Tsang D, Wagstaff J, Parmar MK; STAMPEDE investigators..

Lancet. 2016 Mar 19;387(10024):1163-77. doi: 10.1016/S0140-6736(15)01037-5.

PMID:26719232

Role of multiparametric magnetic resonance imaging in early detection of prostate cancer.

De Visschere PJ, Briganti A, Fütterer JJ, Ghadjar P, Isbarn H, Massard C, Ost P, Sooriakumaran P, Surcel CI, Valerio M, van den Bergh RC, Ploussard G, Giannarini G, Villeirs GM.

Insights Imaging. 2016 Apr;7(2):205-14. doi: 10.1007/s13244-016-0466-9. Review.

PMID:26847758

The Prevalence of Clinically Significant Prostate Cancer According to Commonly Used Histological Thresholds in Men Undergoing Template Prostate Mapping Biopsies.

Valerio M, Anele C, Bott SR, Charman SC, van der Meulen J, El-Mahallawi H, Emara AM, Freeman A, Jameson C, Hindley RG, Montgomery BS, Singh PB, Ahmed HU, Emberton M.

J Urol. 2016 May;195(5):1403-8. doi: 10.1016/j.juro.2015.11.047.

PMID: 26626221

Radiation Therapy after Radical Prostatectomy: Implications for Clinicians.

Herrera FG, Berthold DR.

Front Oncol. 2016 May 9;6:117. doi: 10.3389/fonc.2016.00117. Review.

PMID:27242957

Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991.

Bolla M, Maingon P, Carrie C, Villa S, Kitsios P, Poortmans PM, Sundar S, van der Steen-Banasik EM, Armstrong J, Bosset JF, Herrera FG, Pieters B, Slot A, Bahl A, Ben-Yosef R, Boehmer D, Scrase C, Renard L, Shash E, Coens C, van den Bergh AC, Collette L.

J Clin Oncol. 2016 May 20;34(15):1748-56. doi: 10.1200/JCO.2015.64.8055.

PMID:26976418

Enzalutamide in Patients With Castration-Resistant Prostate Cancer Progressing After Docetaxel: Retrospective Analysis of the Swiss Enzalutamide Named Patient Program.

Papazoglou D, Wannesson L, Berthold D, Cathomas R, Gillessen S, Rothermundt C, Hasler L, Winterhalder R, Barth A, Mingrone W, Nussbaum CU, von Rohr L, von Burg P, Schmid M, Richner J, Baumann S, Kühne R, Stenner F, Rothschild SI.

Clin Genitourin Cancer. 2016 Jun 23. pii: S1558-7673(16)30162-8. doi: 10.1016/j.clgc.2016.06.011. [Epub ahead of print]

PMID:27450512

The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial.

El-Shater Bosaily A, Valerio M, Hu Y, Freeman A, Jameson C, Brown L, Kaplan R, Hindley RG, Barratt D, Emberton M, Ahmed HU.

Prostate Cancer Prostatic Dis. 2016 Sep;19(3):258-63. doi: 10.1038/pcan.2016.7.

PMID: 27401032

Nanoknife Electroporation Ablation Trial: A Prospective Development Study Investigating Focal Irreversible Electroporation for Localized Prostate Cancer.

Valerio M, Dickinson L, Ali A, Ramachadran N, Donaldson I, Mccartan N, Freeman A, Ahmed HU, Emberton M.

J Urol. 2016 Sep 30. pii: S0022-5347(16)31410-0. doi: 10.1016/j.juro.2016.09.091. [Epub ahead of print]

PMID: 27697580

Transperineal template prostate-mapping biopsies: an evaluation of different protocols in the detection of clinically significant prostate cancer.

Valerio M, Anele C, Charman SC, van der Meulen J, Freeman A, Jameson C, Singh PB, Emberton M, Ahmed HU.

BJU Int. 2016 Sep;118(3):384-90. doi: 10.1111/bju.13306.

PMID:26332050

Focal therapy as primary treatment for localized prostate cancer: definition, needs and future.

Ouzzane A, Betrouni N, Valerio M, Rastinehad A, Colin P, Ploussard G.

Future Oncol. 2016 Nov 24. [Epub ahead of print]

PMID:27882770

Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: A prospective development study.

Valerio M, Shah TT, Shah P, Mccartan N, Emberton M, Arya M, Ahmed HU.

Urol Oncol. 2016 Dec 7. pii: S1078-1439(16)30374-X. doi: 10.1016/j.urolonc.2016.11.008. [Epub ahead of print]

PMID: 27955940